PET imaging tracer safety study in healthy volunteers
Part of Brain & nervous system clinical trials.
This early-stage study tests a new PET imaging agent (a radioactive tracer used in medical imaging) to understand how it moves through the body and the radiation dose it delivers. Researchers need healthy volunteers to help establish whether this imaging tool is safe for future patient use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 60 years old and in generally good health
- Not take prescription drugs, herbal supplements, or most over-the-counter medications for 2–4 weeks before the study
- Not have had significant radiation exposure (like radiation therapy) in the past year
- Not have donated blood or lost 400+ ml of blood in the past 8 weeks
- Not have a history of drug or alcohol abuse in the past 12 months, and no tobacco use in the past 3 months
- If female and able to become pregnant: use effective birth control for 14 days before and 24 hours after the PET scan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a very low dose of a radioactive tracer (18F-flurpiridaz) for PET scans of the heart. It aims to see if using less radiation still produces clear images, which may be safer for patients who need repeated scans.
This study tests a new way to take brain imaging scans (PET scans) using a very small amount of radioactive tracer. Researchers want to see if they can get clear pictures of your brain while reducing your radiation exposure compared to standard scans.
This study tests a new radioactive dye called [18F]GATT-44 to see how well it can show a specific brain protein on a PET scan. It may help researchers better understand brain conditions in the future.
This study tests if a very low dose of a standard PET scan tracer (FDG) can produce clear images. It may help people who need a PET scan but are concerned about radiation exposure.
This study tests a new imaging agent that may help show immune activity in the body using a PET scan. It is being tested in healthy volunteers to see how it behaves and to help plan future studies.
This trial tests a new way to take PET scan pictures using a very low amount of a radioactive tracer that targets a protein called SSTR2. It is designed to see if these scans can work well while reducing radiation exposure for patients with certain types of tumors.
Hear when a new Healthy Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.